Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT04864145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 210 participants
- Registry
-
NCT04864145
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04864145. Randomized; single masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2026-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
- Acronym
- SEASON-AR
- Condition
- Aortic Valve Disease
- Intervention (Device)
- Transcatheter Aortic Valve Implantation
- Intervention (Drug)
- Medical therapy
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
Record details
- Record id
cardio:ct-nct04864145- Content hash
0a46b00c66e969bd3c2abcdab4d90f76fa41621954a5e44c76f6519ba51f29d5